Clinical trials
Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central European Leukemia Study Group | 1 |
| First Affiliated Hospital of Harbin Medical University | 1 |
| German CML Study Group | 1 |
| III. Medizinische Klinik Mannheim | 1 |
| McMaster University | 1 |
| Medical Research Council | 1 |
| Ministry of Health, Malaysia | 1 |
| Seoul St. Mary's Hospital | 1 |
| Sheba Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 9 |
| Leukemia, Myeloid, Chronic-Phase | 4 |
| Leukemia | 3 |
| Hematologic Neoplasms | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1 |
| Lymphoma | 1 |
| Myelodysplastic Syndromes | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.